Abstract |
The time course of the inhibition of cholesterol synthesis by low and high doses of mevinolin and monacolin X were studied in normal human skin fibroblasts, fibroblasts without low density lipoprotein receptor and HepG2 hepatoma cells. Low doses of the inhibitors (0.2 ng/mL) caused a sharp decrease in the rate of cholesterol synthesis during the first 2-3 h, which gradually increased to about 40% during the next 6 h. Further incubation led to a decrease or stabilization of the cholesterol synthesis rate. High doses of the drugs (100 mg/mL) strongly inhibited cholesterol synthesis during the first 2-3 h, followed by a moderate increase during the next 20 h. No drug or tissue selectivity was observed.
|
Authors | D D Sviridov, A Endo, M Y Pavlov, V S Repin |
Journal | Lipids
(Lipids)
Vol. 28
Issue 6
Pg. 569-71
(Jun 1993)
ISSN: 0024-4201 [Print] United States |
PMID | 8355584
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Anticholesteremic Agents
- Naphthalenes
- monacolin X
- Cholesterol
- Lovastatin
|
Topics |
- Anticholesteremic Agents
(pharmacology)
- Cholesterol
(biosynthesis)
- Dose-Response Relationship, Drug
- Fibroblasts
(drug effects, metabolism)
- Humans
- Hyperlipoproteinemia Type II
(metabolism)
- Lovastatin
(pharmacology)
- Naphthalenes
(pharmacology)
- Skin
(metabolism)
- Tumor Cells, Cultured
(drug effects, metabolism)
|